Literature DB >> 24557667

Absence of FHIT expression is associated with apoptosis inhibition in colorectal cancer.

Jie Cao1, Xiaoping Chen, Wanglin Li, Jie Xia, Hong Du, Weibiao Tang, Shanming Chen, Hui Wang, Xiwen Chen, Huanqing Xiao, Yuyuan Li.   

Abstract

The fragile histidine triad (FHIT) gene, a candidate tumor suppressor gene located at 3p14.2, has been shown to be involved in the carcinogenesis of many human tissues, including digestive tract tissues. However, the expression and the role of the FHIT in the initiation and the development of the colorectal cancer (CRC) are poorly understood. We have shown that the FHIT gene exhibits significantly decreased expression in human CRC compared to colorectal adenoma and normal colorectal tissue by tissue microarray (TMA). The positive rate of FHIT gene expression in normal colorectal tissue, adenoma and adenocarcinoma were 93.75%, 68.75% and 46.25%, respectively. We show this decreased expression to be significantly correlated with the progression of colorectal carcinoma (P<0.05) as well as with differentiation and lymph node metastasis (P<0.05). We detected two somatic alterations in the FHIT gene in human CRC. The presence of this mutation correlated significantly with decreased FHIT expression in the human CRC. In our present study we tested the hypothesis that the decreased FHIT expression resulted in apoptosis inhibition associated with abnormal expression of apoptosis related proteins. To test this hypothesis we did a series of experiments. In the first test, we assessed apoptosis status using a standard TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling) assay by comparing FHIT-positive CRC vs. FHIT-negative CRC. In the second experiment, the protein expression of the FHIT and other apoptosis related proteins (Bax, Bcl-2 and Survivin) were measured in human CRC by TMA. Our combined results demonstrate the mutation in the FHIT gene significantly reduced FHIT expression in human CRC. Both TUNEL and TMA experiments demonstrated significantly inhibited apoptosis by down-regulation of Bax and the up-regulation of Survivin and Bcl-2. Collectively, these studies identify the mechanism by which an important tumor suppressor gene, FHIT is inactivated specifically in human CRC contributing to our understanding of the mechanism of colorectal carcinogenesis.

Entities:  

Year:  2007        PMID: 24557667     DOI: 10.1007/s11684-007-0028-0

Source DB:  PubMed          Journal:  Front Med China        ISSN: 1673-7342


  23 in total

1.  Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer.

Authors:  Thomas Knösel; Anna Emde; Karsten Schlüns; Yuan Chen; Karsten Jürchott; Matthias Krause; Manfred Dietel; Iver Petersen
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

Review 2.  Cell death in development.

Authors:  D L Vaux; S J Korsmeyer
Journal:  Cell       Date:  1999-01-22       Impact factor: 41.582

3.  Structure and expression of the human FHIT gene in normal and tumor cells.

Authors:  T Druck; P Hadaczek; T B Fu; M Ohta; Z Siprashvili; R Baffa; M Negrini; K Kastury; M L Veronese; D Rosen; J Rothstein; P McCue; M G Cotticelli; H Inoue; C M Croce; K Huebner
Journal:  Cancer Res       Date:  1997-02-01       Impact factor: 12.701

4.  Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions.

Authors:  X P Hao; J E Willis; T G Pretlow; J S Rao; G T MacLennan; I C Talbot; T P Pretlow
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

5.  Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.

Authors:  K Pavelić; S Krizanac; T Cacev; M P Hadzija; S Radosević; I Crnić; S Levanat; S Kapitanović
Journal:  Mol Med       Date:  2001-07       Impact factor: 6.354

6.  Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B.

Authors:  F Boldog; R M Gemmill; J West; M Robinson; L Robinson; E Li; J Roche; S Todd; B Waggoner; R Lundstrom; J Jacobson; M R Mullokandov; H Klinger; H A Drabkin
Journal:  Hum Mol Genet       Date:  1997-02       Impact factor: 6.150

7.  Abnormal FHIT transcripts in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases.

Authors:  S Hayashi; K Tanimoto; K Hajiro-Nakanishi; E Tsuchiya; M Kurosumi; Y Higashi; K Imai; K Suga; K Nakachi
Journal:  Cancer Res       Date:  1997-05-15       Impact factor: 12.701

8.  Clinicopathologic features and FHIT gene expression in sporadic colorectal adenocarcinomas.

Authors:  C Luceri; F Guglielmi; C De Filippo; G Caderni; E Mini; A Biggeri; C Napoli; F Tonelli; F Cianchi; P Dolara
Journal:  Scand J Gastroenterol       Date:  2000-06       Impact factor: 2.423

9.  Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death.

Authors:  E Yang; J Zha; J Jockel; L H Boise; C B Thompson; S J Korsmeyer
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

Review 10.  Bcl-2 and the regulation of programmed cell death.

Authors:  J C Reed
Journal:  J Cell Biol       Date:  1994-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.